Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
9.74
+1.54 (18.78%)
At close: Jan 3, 2025, 4:00 PM
9.99
+0.25 (2.57%)
After-hours: Jan 3, 2025, 7:56 PM EST

Champions Oncology Market Cap

Champions Oncology has a market cap or net worth of $133.43 million as of January 3, 2025. Its market cap has increased by 115.21% in one year.

Market Cap
133.43M
Enterprise Value
137.45M
1-Year Change
115.21%
Ranking
Category
Stock Price
$9.74

Market Cap Chart

Since February 2, 2007, Champions Oncology's market cap has increased from $10.70M to $133.43M, an increase of 1,146.98%. That is a compound annual growth rate of 15.11%.

History

DateMarket Cap% Change
Jan 3, 2025134.60M13.68%
Dec 31, 2024118.40M54.97%
Dec 29, 202376.40M25.04%
Dec 30, 202261.10M-45.93%
Dec 31, 2021113.00M-21.69%
Dec 31, 2020144.30M49.07%
Dec 31, 201996.80M8.04%
Dec 31, 201889.60M110.33%
Dec 29, 201742.60M53.79%
Dec 30, 201627.70M-10.93%
Dec 31, 201531.10M-6.89%
Dec 31, 201433.40M-58.35%
Dec 31, 201380.20M468.79%
Dec 31, 201214.10M-59.94%
Dec 30, 201135.20M6.02%
Dec 31, 201033.20M26.24%
Dec 31, 200926.30M-26.74%
Dec 31, 200835.90M-19.14%
Dec 31, 200744.40M314.95%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 701.55B
UnitedHealth Group 473.19B
Novo Nordisk 390.00B
Johnson & Johnson 347.81B
AbbVie 319.59B
Merck & Co. 250.27B
AstraZeneca 203.90B
Thermo Fisher Scientific 203.12B
Market Cap Rankings